Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Uncontrolled, Pilot-study Assessing the Efficacy of Octreotide Long-acting Release to Decrease Transfusion Requirements and Endoscopy Frequency in Patients With Rendu-Osler-Weber and Gastrointestinal Bleeding

NCT02874326 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02874326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02874326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Uncontrolled, Pilot-study Assessing the Efficacy of Octreotide Long-acting Release to Decrease Transfusion Requirements and Endoscopy Frequency in Patients With Rendu-Osler-Weber and Gastrointestinal Bleeding
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2016
Completion date
October 31, 2018
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, gastrointestinal hemorrhage, hereditary hemorrhagic telangiectasia